pharma-company /Medicinal products /Active ingredients

Rx · PZN 19694005

TEPEZZA 500 mg powder for a concentrate for preparation of a solution for infusion

German trade nameTEPEZZA 500 mg Pulver für einer Konzentrat zur Herstellung einer Infusionslösung

Active ingredientTeprotumumab

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €6,003

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for TEPEZZA 500 mg powder for a concentrate for preparation of a solution for infusion.

Review purchasing terms

TEPEZZA 500 mg powder for a concentrate for preparation of a solution for infusion contains the active ingredient Teprotumumab. One pack size is recorded (PZN 19694005). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.


TEPEZZA 500 mg powder for a concentrate for preparation of a solution for infusion was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.